These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 6293886)
1. Gonadal function in men with testis cancer. Berthelsen JG; Skakkebaek NE Fertil Steril; 1983 Jan; 39(1):68-75. PubMed ID: 6293886 [TBL] [Abstract][Full Text] [Related]
2. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288 [TBL] [Abstract][Full Text] [Related]
3. Impaired testicular function in patients with carcinoma-in-situ of the testis. Petersen PM; Giwercman A; Hansen SW; Berthelsen JG; Daugaard G; Rørth M; Skakkebaek NE J Clin Oncol; 1999 Jan; 17(1):173-9. PubMed ID: 10458231 [TBL] [Abstract][Full Text] [Related]
4. Germ cell function and hormonal status in patients with testicular cancer. Hansen PV; Trykker H; Andersen J; Helkjaer PE Cancer; 1989 Aug; 64(4):956-61. PubMed ID: 2545331 [TBL] [Abstract][Full Text] [Related]
5. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. Carroll PR; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bajorunas D; Fair WR; Chaganti RS J Urol; 1987 Mar; 137(3):420-3. PubMed ID: 3029434 [TBL] [Abstract][Full Text] [Related]
6. Gonadal function and fertility in patients with bilateral testicular germ cell malignancy. Jacobsen KD; Fosså SD; Bjøro TP; Aass N; Heilo A; Stenwig AE Eur Urol; 2002 Sep; 42(3):229-38; discussion 237-8. PubMed ID: 12234507 [TBL] [Abstract][Full Text] [Related]
7. Gonadal function after multimodality treatment in men with testicular germ cell cancer. Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293 [TBL] [Abstract][Full Text] [Related]
8. Human chorionic gonadotropin beta-subunit in human semen. Saito S; Kumamoto Y; Ito N; Kurohata T Arch Androl; 1988; 20(1):87-99. PubMed ID: 2455489 [TBL] [Abstract][Full Text] [Related]
9. Fertility and hormonal function in patients with a nonseminomatous tumor of the testis. Nijman JM; Schraffordt Koops H; Kremer J; Willemse PH; Sleijfer DT; Oldhoff J Arch Androl; 1985; 14(2-3):239-46. PubMed ID: 2415075 [TBL] [Abstract][Full Text] [Related]
10. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer. Spermon JR; Ramos L; Wetzels AM; Sweep CG; Braat DD; Kiemeney LA; Witjes JA Hum Reprod; 2006 Jul; 21(7):1781-6. PubMed ID: 16601009 [TBL] [Abstract][Full Text] [Related]
11. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096 [TBL] [Abstract][Full Text] [Related]
12. Serum testosterone, LH, and FSH in patients with testicular cancer before and after radio- and chemotherapy. Berthelsen JG; Engelholm SA; von der Maase H; Rørth M Scand J Urol Nephrol; 1983; 17(3):287-90. PubMed ID: 6316483 [TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours. Reznik Y; Rieu M; Kuhn JM; Mandard JC; Bottet P; Lemonnier D; Bekka S; Mahoudeau J Clin Endocrinol (Oxf); 1993 May; 38(5):487-93. PubMed ID: 8392454 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man. Van Thiel DH; Sherins RJ; Myers GH; De Vita VT J Clin Invest; 1972 Apr; 51(4):1009-19. PubMed ID: 4552337 [TBL] [Abstract][Full Text] [Related]
15. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. Giwercman A; von der Maase H; Berthelsen JG; Rørth M; Bertelsen A; Skakkebaek NE J Clin Endocrinol Metab; 1991 Sep; 73(3):596-603. PubMed ID: 1908483 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer. Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493 [TBL] [Abstract][Full Text] [Related]
17. Altered Leydig cell function in patients with testicular cancer: evidence for bilateral testicular defect. Willemse PH; Sleijfer DT; Sluiter WJ; Schraffordt Koops H; Doorenbos H Acta Endocrinol (Copenh); 1983 Apr; 102(4):616-24. PubMed ID: 6133401 [TBL] [Abstract][Full Text] [Related]
18. Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors. Nome RV; Bjøro T; Paus E; Bjerner J; Fosså SD; Steen R; Nustad K; Bolstad N Clin Biochem; 2018 Feb; 52():73-79. PubMed ID: 29198759 [TBL] [Abstract][Full Text] [Related]
19. Gonadal dysfunction in patients treated for metastatic germ-cell tumors. Leitner SP; Bosl GJ; Bajorunas D J Clin Oncol; 1986 Oct; 4(10):1500-5. PubMed ID: 3020183 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. Bay K; Hartung S; Ivell R; Schumacher M; Jürgensen D; Jorgensen N; Holm M; Skakkebaek NE; Andersson AM J Clin Endocrinol Metab; 2005 Jun; 90(6):3410-8. PubMed ID: 15755855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]